Drug Search Results
More Filters [+]

Magnesium acetate

Alternative Names: magnesium acetate, aminosyn 3.5% m in plastic container, plasma-lyte 56 in plastic container, aminosyn ii 3.5% m in plastic container, aminosyn 3.5% m, freamine iii 3% w/ electrolytes, freamine iii 8.5% w/ electrolytes, procalamine
Latest Update: 2022-03-09
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Belgium | Brazil | Chile | Croatia | Cyprus | Egypt | France | Hong Kong | Hungary | Indonesia | Ireland | Malaysia | New Zealand | Russia | South Africa | Spain | Taiwan | Turkey | United Arab Emirates | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Magnesium acetate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events